ROGER M. PERLMUTTER - 08 Jun 2021 Form 4 Insider Report for NGM BIOPHARMACEUTICALS INC

Role: Director
Signature: /s/ Valerie Pierce, Attorney-in-fact
Issuer symbol: N/A
Transactions as of: 08 Jun 2021
Net transactions value: $0
Form type: 4
Filing time: 10 Jun 2021, 17:34:40 UTC
Next filing: 20 May 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NGM	Stock Option (Right to Buy)	Award	$0	+46,238		$0.000000	46,238	08 Jun 2021	Common Stock	46,238	$17.24	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock option shall vest one-third on the first anniversary of the date of grant, with the remaining shares vesting quarterly over the next two years, such that the option grant will be fully vested on the third anniversary of the date of grant, subject to the Reporting Person's Continuous Service (as defined in the Amended and Restated 2018 Equity Incentive Plan) on each applicable vesting date.

Content

The stock option shall vest one-third on the first anniversary of the date of grant, with the remaining shares vesting quarterly over the next two years, such that the option grant will be fully vested on the third anniversary of the date of grant, subject to the Reporting Person's Continuous Service (as defined in the Amended and Restated 2018 Equity Incentive Plan) on each applicable vesting date.